Browsing: t-all

Groundbreaking CD7 CAR-T therapy from NUS Medicine offers hope for T-cell acute lymphoblastic leukaemia (T-ALL) patients. Early case reports show 16 of 17 achieved remission, marking a significant cancer treatment advancement for relapsed/refractory T-ALL.

Three T-ALL patients – Viet Tai, Maria, and Hannah – share their inspiring cancer journeys through an innovative CD7 CAR-T therapy treatment, pioneered by researchers and clinicians from the NUS Medicine and NUHS and cultivated in-house by a modest laboratory in Singapore.